A GSH ‐Responsive Immune‐Stimulating Polypeptide Hydrogel Loaded with Chemotherapeutics, IDO Inhibitor and Immune Checkpoint Blocking Antibody for Enhanced Anti‐Tumor Chemo‐Immunotherapy
Chinese Journal of Chemistry · 2024-12 · 42 (23) · 2957-2969
DOI: 10.1002/cjoc.202400475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Chemistry, online erschienen am 08.08.2024. Verfasst von Junfeng Ding und 4 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Comprehensive Summary Due to the immunosuppressive tumor microenvironment (TME), T cells are usually inactivated and tend to differentiate into regulatory T cells (Tregs) in the tumor tissues, which seriously hinders the anti‐tumor efficiency of immunotherapy. In this study, an immune‐stimulating polypeptide hydrogel conjugated with an indoleamine‐2,3‐dioxygenase (IDO) inhibitor, 1‐methyl‐ D ‐tryptophan (D1MT), through a glutathione (GSH)‐responsive spacer was developed as an immunotherapy platform capable of regulating the TME. A combined immunotherapy system was further constructed through encapsulating doxorubicin (Dox) and immune checkpoint blocking antibody targeting programmed cell death protein 1 (aPD‐1) in the hydrogel. Dox released from the hydrogel could cause the immunogenic cell death (ICD) of tumor cells and induce the maturation of antigen presenting cells (APCs). After intratumoral injection, the multiple agent‐loaded hydrogel elicited effective anti‐tumor immunity in mice bearing B16F10 melanoma. Moreover, compared with the control hydrogel without D1MT, the immune‐stimulating hydrogel showed better efficiency in improving the immunosuppressive TME with increased number of activated T cells and reduced number of Tregs. Therefore, the immune‐stimulating hydrogel has great potential as a stimuli‐responsive platform for regulating suppressive TME and enhanced anti‐tumor chemo‐immunotherapy.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ding, J., Wang, T., Rong, Y., He, C., & Chen, X. (2024). A GSH ‐Responsive Immune‐Stimulating Polypeptide Hydrogel Loaded with Chemotherapeutics, IDO Inhibitor and Immune Checkpoint Blocking Antibody for Enhanced Anti‐Tumor Chemo‐Immunotherapy. Chinese Journal of Chemistry, 42(23), 2957-2969. https://doi.org/10.1002/cjoc.202400475
Vancouver
Ding J, Wang T, Rong Y, He C, Chen X. A GSH ‐Responsive Immune‐Stimulating Polypeptide Hydrogel Loaded with Chemotherapeutics, IDO Inhibitor and Immune Checkpoint Blocking Antibody for Enhanced Anti‐Tumor Chemo‐Immunotherapy. Chinese Journal of Chemistry. 2024;42(23):2957-2969. doi:10.1002/cjoc.202400475
BibTeX
@article{Ding2024,
author = {Ding, Junfeng and Wang, Tianran and Rong, Yan and He, Chaoliang and Chen, Xuesi},
title = {A GSH ‐Responsive Immune‐Stimulating Polypeptide Hydrogel Loaded with Chemotherapeutics, IDO Inhibitor and Immune Checkpoint Blocking Antibody for Enhanced Anti‐Tumor Chemo‐Immunotherapy},
journal = {Chinese Journal of Chemistry},
year = {2024},
volume = {42},
number = {23},
pages = {2957--2969},
doi = {10.1002/cjoc.202400475}
}
EUVIMED